RHONDA WHITE: Open Payments
NPI 1922096510 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 28 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $82 |
| ARGENX US, INC. | 2 | $66 |
| Janssen Biotech, Inc. | 3 | $60 |
| HARMONY BIOSCIENCES LLC | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Biogen, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $28 |
Products named: VYVGART HYTRULO, TREMFYA, WAKIX, LEQEMBI, Bimzelx, Rystiggo, BENLYSTA, HYQVIA.
Industry payments across GA — which companies pay providers there.
